President Donald Trump's Investment Team Dumped AMD in August and Bought Up to $25 Million in One of the Cheapest "Magnificent Seven" Stocks

A U.S. Office of Government Ethics filing showed President Trump's independent investment team reported 517 trades in August, with combined reported values of up to $273 million. The team sold $1,000,001–$5 million of AMD and bought up to $25 million of Meta, while also trimming Nvidia and other holdings; the article cites AI-bubble risk for AMD and Meta's advertising, AI infrastructure plans, and relatively low valuation as potential attractions. These disclosed portfolio trades are notable but do not establish Trump personally directed each transaction.

Analysis

The filing is a weak signal for either stock: a third-party manager’s trades do not establish the president’s investment thesis, and amount ranges plus reporting lags limit what can be inferred about position size or current exposure. Any immediate price response is more likely sentiment and positioning than new information about earnings.

The more important distinction is business-model risk. AMD remains exposed to whether accelerator demand converts into sustained deployments, customer adoption and share gains against NVIDIA and in-house chips. A slowdown in AI infrastructure spending could pressure both growth expectations and valuation. META’s ad business may benefit if AI improves campaign performance, but its proposed compute-rental business adds execution, utilization and capital-intensity risks; owning GPUs does not by itself insulate the company from an AI spending downturn. If scaled, external compute could also intensify competition for cloud workloads, though the article provides no evidence yet on capacity, customers or economics.

Over 1–3 months, prioritize earnings revisions and management commentary on accelerator shipments, customer concentration, ad pricing/conversion and AI-related capital spending over this disclosure. Over 6–18 months, the key test is whether AI investment produces measurable returns or merely expands infrastructure supply. Contrarian point: treating META as a lower-risk AI exposure may understate its capex and monetization uncertainty; treating AMD’s sale as evidence of a negative view is equally unjustified. The article supplies no valuation or financial data adequate to establish either stock as mispriced.

Key Decisions for Investors

• Do not trade the filing itself. Treat the reported transactions as a low-confidence sentiment input, not an endorsement or fundamental catalyst.
• Watch for a conditional META-long/AMD-short relative-value setup only if subsequent earnings revisions support META ad monetization and weaken AMD accelerator demand or share expectations, and valuation analysis confirms the spread is not already priced in. No position is warranted from the article alone.
• For AMD, reassess on accelerator shipment/customer commentary and any guidance change; the bearish thesis weakens if adoption and share gains persist despite broader AI-spending moderation. For META, monitor ad performance alongside capex, compute utilization and external-customer evidence; rising investment without monetization would challenge the bullish case.